Image
Primary Care Is PrEP’d for Prevention Optimizing Sexual Health and Decreasing HIV Risk

Jason Halperin, MD, MPH; Neil Skolnik, MD; Isolde Butler, MD, MPH

Engage in a real-time simulated scenario with a Standardized Patient (SP)

 

SPs are people trained to simulate the symptoms and characteristics of patients you see in your practice. We know you're busy, so we're bringing these SPs to you through our web conferencing platform.

 

Click the Begin Activity button to schedule your real-time SP interaction during this activity.

This activity is presented by National Association for Continuing Education and Integritas Communications.

Faculty

Jason Halperin, MD, MPH (Activity Co-Chair/Presenter)
HIV/ID Innovation Medical Leader
CrescentCare  
Clinical Assistant Professor of Medicine
Tulane University
School of Medicine
New Orleans, Louisiana

Neil Skolnik, MD (Moderator)
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, Pennsylvania

Isolde Butler, MD, MPH (Activity Co-Chair)
Physician Site Supervisor
CrescentCare
New Orleans, Louisiana

Target Audience

This activity is intended for primary care providers (PCPs) involved in the assessment, referral, and multidisciplinary management of sexual health and human immunodeficiency virus (HIV) prevention.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Demonstrate understanding of the epidemiology, burden, and stigma surrounding HIV risk and transmission
  • Initiate a patient-clinician dialogue to discuss and assess sexual health and behaviors and determine HIV risk
  • Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection in the United States to appropriately screen and determine clinical eligibility for PrEP
  • Initiate and provide ongoing monitoring for patients on PrEP for HIV prevention

Course Summary

Initiating an open and honest conversation with patients about their sexual health and determining clinical eligibility for preexposure prophylaxis (PrEP) is often challenging to many primary care providers (PCPs) who may feel uncomfortable and unprepared. This one-hour educational interactive webcast is designed to increase awareness among PCPs of their role in human immunodeficiency virus (HIV) prevention, provide practical tools to improve their comfort and skills in opening dialogues about sexual health, and prepare them to provide full PrEP services.

Planning Committee

Michelle Frisch, MPH, CHCP
Vice President, Operations
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Becky Carney, MSPT
Senior VP, Educational Strategy
Integritas Communications Group
Hoboken, NJ

Jim Kappler, PhD
Integritas Communications Group
Hoboken, NJ

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

Stacey JP Ullman, MHS
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ

Jeanette Ruby, MD
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ

Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education, which includes 1.0 pharmacology hour.

Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. All faculty, moderator and planner conflicts of interest have been resolved through peer review of the content by the Course Director and/or agreement to NACE conflict of interest resolution policies.

The ACCME defines a commercial interest as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providing clinical service directly to patients to be commercial interests - unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest.

Resolution of Personal Conflicts of Interests

NACE requires disclosure of relevant financial relationships with the commercial interest from course directors, faculty, members of the activity planning committee, and others in a position to control the content of the educational activity. Any individual who refuses to disclose his or her relationships will be disqualified from any involvement in the planning, development, teaching/presenting, managing, or evaluation of the educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Jason Halperin, MD, MPH: No financial relationships to disclose

Isolde Butler, MD, MPH: No financial relationships to disclose

Neil Skolnik, MD: Advisory Board Member: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen, Merck & Co., Inc., Mylan, Sanofi Pasteur, Teva; Research: AstraZeneca, Boehringer Ingelheim, Sanofi; Speaker: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline

The planning committee reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Michelle Frisch, MPH, CHCP: No financial relationships to disclose

Sheila Lucas, CWEP: No financial relationships to disclose

Deborah Paschal, CRNP: No financial relationships to disclose

Gregg Sherman, MD: No financial relationships to disclose

Becky Carney, MSPT: No financial relationships to disclose

Christa Master: No financial relationships to disclose

Stacey JP Ullman, MHS: No financial relationships to disclose

Jeanette Ruby, MD: No financial relationships to disclose

Jim Kappler, PhD: No financial relationships to disclose

Statement of Commercial Support

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 75% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 75%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 1.00

credit type CME/CE

release 10/05/2020

expiration 10/04/2021

type Webcast